These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31538903)

  • 1. Association between hTERT Polymorphisms and Female Papillary Thyroid Carcinoma.
    Liu Y; Li Z; Tang X; Li M; Shi F
    Recent Pat Anticancer Drug Discov; 2019; 14(3):268-279. PubMed ID: 31538903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of telomerase reverse transcriptase rs10069690 and rs2736100 polymorphisms with papillary thyroid carcinoma.
    Liu Y; Shi F
    Eur J Cancer Prev; 2020 May; 29(3):259-265. PubMed ID: 31651569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. hTERT gene polymorphism correlates with the risk and the prognosis of thyroid cancer.
    Gong L; Xu Y; Hu YQ; Ding QJ; Yi CH; Huang W; Zhou M
    Cancer Biomark; 2016 Jul; 17(2):195-204. PubMed ID: 27472887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The correlations between DNA methylation and polymorphisms in the promoter region of the human telomerase reverse transcriptase (hTERT) gene with postoperative recurrence in patients with thyroid carcinoma (TC).
    Li JJ; Zheng PCJ; Wang YZ
    World J Surg Oncol; 2017 Jun; 15(1):114. PubMed ID: 28587656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional evaluation of TERT-CLPTM1L genetic variants associated with susceptibility of papillary thyroid carcinoma.
    Ge M; Shi M; An C; Yang W; Nie X; Zhang J; Lv Z; Li J; Zhou L; Du Z; Yang M
    Sci Rep; 2016 May; 6():26037. PubMed ID: 27185198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in human telomerase reverse transcriptase (hTERT) gene and susceptibility to gastric cancer in a Turkish population: Hospital-based case-control study.
    Bayram S; Ülger Y; Sümbül AT; Kaya BY; Genç A; Rencüzoğullari E; Dadaş E
    Gene; 2016 Jul; 585(1):84-92. PubMed ID: 27016301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of human telomerase reverse transcriptase gene polymorphisms, serum levels, and telomere length with renal cell carcinoma risk and pathology.
    de Martino M; Taus C; Lucca I; Hofbauer SL; Haitel A; Shariat SF; Klatte T
    Mol Carcinog; 2016 Oct; 55(10):1458-66. PubMed ID: 26294352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of papillary thyroid cancer risk loci identified by genome-wide association studies.
    Wei WJ; Lu ZW; Wang Y; Zhu YX; Wang YL; Ji QH
    Cancer Genet; 2015 Mar; 208(3):68-75. PubMed ID: 25746573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological significance of the single nucleotide polymorphism, rs2853669 within the TERT promoter in papillary thyroid carcinoma.
    Hirokawa T; Arimasu Y; Chiba T; Fujiwara M; Kamma H
    Pathol Int; 2020 Apr; 70(4):217-223. PubMed ID: 31943527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in human telomerase reverse transcriptase (hTERT) gene, gene- gene and gene-smoking interaction with susceptibility to gastric cancer in Chinese Han population.
    Zhang J; Ju H; Gao JR; Jiao XL; Lu Y
    Oncotarget; 2017 Mar; 8(12):20235-20243. PubMed ID: 28423629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association analysis between the interaction of RAS family genes mutations and papillary thyroid carcinoma in the Han Chinese population.
    Jin M; Li Z; Sun Y; Zhang M; Chen X; Zhao H; Yu Q
    Int J Med Sci; 2021; 18(2):441-447. PubMed ID: 33390813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine mapping of 14q13 reveals novel variants associated with different histological subtypes of papillary thyroid carcinoma.
    Jendrzejewski J; Liyanarachchi S; Eiterman A; Thomas A; He H; Nagy R; Senter L; Sworczak K; de la Chapelle A
    Int J Cancer; 2019 Feb; 144(3):503-512. PubMed ID: 30350351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomere length and
    Mervic A; Goricar K; Blagus T; Franko A; Trebusak-Podkrajsek K; Fikfak MD; Dolzan V; Kovac V
    Radiol Oncol; 2024 Mar; 58(1):87-98. PubMed ID: 38378028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of CASP3 rs4647610 and rs4647602 polymorphisms on tumour size and cancer stage in papillary thyroid carcinoma.
    Heidari Z; Eskandari M; Aryan A; Rostamzad F; Salimi S
    Br J Biomed Sci; 2020 Jul; 77(3):129-134. PubMed ID: 32151194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase reverse transcriptase mutations are independent predictor of disease-free survival in Middle Eastern papillary thyroid cancer.
    Bu R; Siraj AK; Divya SP; Kong Y; Parvathareddy SK; Al-Rasheed M; Al-Obaisi KAS; Victoria IG; Al-Sobhi SS; Al-Dawish M; Al-Dayel F; Al-Kuraya KS
    Int J Cancer; 2018 May; 142(10):2028-2039. PubMed ID: 29266240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of TP53 and P21 gene polymorphisms on papillary thyroid carcinoma susceptibility and clinical/pathological features.
    Heidari Z; Harati-Sadegh M; Arian A; Maruei-Milan R; Salimi S
    IUBMB Life; 2020 May; 72(5):922-930. PubMed ID: 31895498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variations in TAS2R3 and TAS2R4 bitterness receptors modify papillary carcinoma risk and thyroid function in Korean females.
    Choi JH; Lee J; Yang S; Lee EK; Hwangbo Y; Kim J
    Sci Rep; 2018 Oct; 8(1):15004. PubMed ID: 30301923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of MDM2 309T>G (rs2279744) and I/D (rs3730485) polymorphisms and haplotypes in risk of papillary thyroid carcinoma, tumor stage, tumor size, and early onset of tumor: A case control study.
    Maruei-Milan R; Heidari Z; Salimi S
    J Cell Physiol; 2019 Aug; 234(8):12934-12940. PubMed ID: 30548972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ detection of hTERT mRNA relates to Ki-67 labeling index in papillary thyroid carcinoma.
    Chou SJ; Chen CM; Harn HJ; Chen CJ; Liu YC
    J Surg Res; 2001 Jul; 99(1):75-83. PubMed ID: 11421607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk genetic polymorphism and haplotype associated with papillary thyroid cancer and their relation to associated diseases in Slovak population.
    Duffek M; Skerenova M; Halasova E; Sarlinova M; Dzian A; Repiska V; Dobrovodsky A; Mistuna D; Bernadic M; Matakova T
    Bratisl Lek Listy; 2022; 123(7):475-48. PubMed ID: 35907052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.